24-week real-world study of Atectura for asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study follows people with asthma who are starting or using Atectura inhalation capsules to see how they do in everyday practice over 24 weeks. It may help your care team learn whether Atectura works well and safely outside a tightly controlled setting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 12 years old and have a doctor’s diagnosis of asthma
- You must be prescribed Atectura capsules (indacaterol/mometasone) to use with the Breezhaler inhaler
- You must be willing to sign consent for the study’s data collection (and if under 18, a parent/guardian consent is needed)
- You should not have had an allergy (a hypersensitivity reaction) to Atectura or its ingredients
- You must not have lactose-related genetic problems (because the medicine contains lactose)
- Your asthma should not be in a sudden flare-up right now that needs a quick rescue inhaler
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses special imaging to look at how air moves through your lungs. It may help doctors understand asthma better and could lead to better treatments.
This study tests a new inhaler (PT027) against another inhaler (PT007) for teens aged 12 to 17 with asthma. It looks at how well the new inhaler works when used as needed, and if it is safe.
This study tests a new combination inhaler (fluticasone propionate and albuterol) for people with asthma age 12 and older. It helps see if this inhaler works better than a placebo in controlling asthma symptoms and preventing attacks.
This study tests a new medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with their current inhalers. It is for adults who have had asthma for at least a year, have had recent flare-ups needing steroids, and are not taking other biologic treatments.
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
This study tests a new combination inhaler (budesonide/albuterol) against another asthma inhaler in adults whose asthma is not well controlled on their current medications. It aims to see if the new inhaler can reduce serious asthma attacks and improve symptoms.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.